MassTag Polymerase Chain Reaction for Differential Diagnosis of Viral Hemorrhagic Fevers
Gustavo Palacios*
1, Thomas Briese*
1
, Vishal Kapoor*, Omar Jabado*, Zhiqiang Liu*, Marietjie Venter†, Junhui Zhai*, Neil Renwick*, Allen Grolla‡, Thomas W. Geisbert§, Christian Drosten¶, Jonathan S. Towner#, Jingyue Ju*, Janusz Paweska**, Stuart T. Nichol#, Robert Swanepoel**, Heinz Feldmann‡††, Peter B. Jahrling‡‡, and W. Ian Lipkin*
Author affiliations: *Columbia University, New York, New York, USA; †University of Pretoria and National Health Laboratory Services, Pretoria, South Africa; ‡Public Health Agency of Canada, Winnipeg, Manitoba, Canada; §United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA; ¶Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany; #Centers for Disease Control and Prevention, Atlanta, Georgia, USA; **National Institute for Communicable Diseases, Sandringham, South Africa; ††University of Manitoba, Winnipeg, Manitoba, Canada; ‡‡National Institutes of Allergy and Infectious Diseases Integrated Research Facility, Fort Detrick, Frederick, Maryland, USA
Main Article
Table 2
Sensitivity of detection with synthetic RNA standards
Pathogen* |
Detection threshold (RNA copies)† |
ZEBOV |
20 |
SEBOV |
20 |
MARV |
20 |
LASV |
20 |
RVFV |
20 |
CCHFV |
50 |
HNTV |
20 |
SEOV |
50 |
YFV |
20 |
KFDV |
20 |
Main Article
Page created: January 24, 2012
Page updated: January 24, 2012
Page reviewed: January 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.